Projects
Research
A randomized, controlled, observer-blind, phase 1/2a study to evaluate the safety, reactogenicity, and immunogenicity of Ad26.RSV.preF in RSV-seronegative toddlers 12 to 24 months of ageJennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical Research Manager Head, Vaccine Trials Group Jennifer completed her Diploma of Nursing in 1986 at Fremantle
Research
A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 in healthy infants (PNEU-PED-EU-1)Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical Research Manager Head, Vaccine Trials Group Jennifer completed her Diploma of Nursing in 1986 at Fremantle
Research
A phase 3, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety and tolerability of V114 in healthy infants (PNEULINK)Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical Research Manager Head, Vaccine Trials Group Jennifer completed her Diploma of Nursing in 1986 at Fremantle
Research
Young Minds MatterSteve Sarah Zubrick Johnson FASSA, FAAMHS, MSc AM PhD BA, PostGradDip; PhD Honorary Emeritus Research Fellow Senior Research Fellow 08 6319 1409 Stephen.zubrick@thekids.org.au Sarah.Johnson@thekids.org.au Honorary Emeritus Research Fellow Senior
Research
WA Department of Health Merit Awards - Project - Improving Aboriginal health disparities: the influence of education, child protection and justice systems over time and across generationsFrancis Sarah Mitrou Johnson BEc BA, PostGradDip; PhD Program Head, Population Health, and Team Head, Human Development and Community Wellbeing Senior Research Fellow 08 6319 1499 francis.mitrou@thekids.org.au Sarah.Johnson@thekids.org.au Program